Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah E Snider

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors|March 22, 2019
The phenotype of recovery III: Delay discounting predicts abstinence self-efficacy among individuals in recovery from substance use disordersLiqa N Athamneh, William B DeHart, Derek Pope, et al.
Current Topics in Behavioral Neurosciences|May 29, 2020
Reinforcer Pathology: Implications for Substance Abuse InterventionWarren K Bickel, Liqa N Athamneh, Sarah E Snider, et al.
European Journal of Pharmacology|February 7, 2012
The glial cell modulators, ibudilast and its amino analog, AV1013, attenuate methamphetamine locomotor activity and its sensitization in miceSarah E Snider, Sarah A Vunck, Edwin J C G van den Oord, et al.
AIDS (London, England)|April 16, 2014
Ibudilast (AV411), and its AV1013 analog, reduce HIV-1 replication and neuronal death induced by HIV-1 and morphineNazira El-Hage, Myosotys Rodriguez, Elizabeth M Podhaizer, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors|March 22, 2019
The phenotype of recovery III: Delay discounting predicts abstinence self-efficacy among individuals in recovery from substance use disordersLiqa N Athamneh, William B DeHart, Derek Pope, et al.
Current Topics in Behavioral Neurosciences|May 29, 2020
Reinforcer Pathology: Implications for Substance Abuse InterventionWarren K Bickel, Liqa N Athamneh, Sarah E Snider, et al.
European Journal of Pharmacology|February 7, 2012
The glial cell modulators, ibudilast and its amino analog, AV1013, attenuate methamphetamine locomotor activity and its sensitization in miceSarah E Snider, Sarah A Vunck, Edwin J C G van den Oord, et al.
AIDS (London, England)|April 16, 2014
Ibudilast (AV411), and its AV1013 analog, reduce HIV-1 replication and neuronal death induced by HIV-1 and morphineNazira El-Hage, Myosotys Rodriguez, Elizabeth M Podhaizer, et al.
Pageof 3